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Abstract Metabolic adaptation to weight changes relates to
body weight control, obesity and malnutrition. Adaptive ther-
mogenesis (AT) refers to changes in resting and non-resting
energy expenditure (REE and nREE) which are independent
from changes in fat-free mass (FFM) and FFM composition.
AT differs in response to changes in energy balance. With
negative energy balance, AT is directed towards energy spar-
ing. It relates to a reset of biological defence of body weight
and mainly refers to REE. After weight loss, ATof nREE adds
to weight maintenance. During overfeeding, energy dissipa-
tion is explained by AT of the nREE component only. As to
body weight regulation during weight loss, AT relates to two
different set points with a settling between them. During early
weight loss, the first set is related to depleted glycogen stores
associated with the fall in insulin secretion where AT adds to
meet brain’s energy needs. During maintenance of reduced
weight, the second set is related to low leptin levels keeping
energy expenditure low to prevent triglyceride stores getting
too low which is a risk for some basic biological functions
(e.g., reproduction). Innovative topics of AT in humans are on
its definition and assessment, its dynamics related to weight
loss and its constitutional and neuro-endocrine determinants.
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(FFM) . Total bodywater (TBW) . Obesity . Leptin . Insulin .
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Introduction
Weight loss and weight gain are associated with declines and
increases in energy expenditure (EE), which mainly follow
changes in the metabolically active component of the body,
i.e. fat-free mass (FFM). Most of these changes are non-
adaptive and occur passively. However, weight change does
not exactly follow prediction based on calculation of energy
imbalance. This is explained by FFM-independent metabolic
adaptations, i.e. adaptive thermogenesis (AT). AT limits
changes in energy stores in response to varying energy intake
and/or EE, e.g. AT explained about 50 % of the less-than-
expected weight loss in obese patients [1, 2]. Energy sparing
(with weight loss) and energy dissipation (with weight gain)
are related to the issues of obesity as well as voluntary (e.g.
due to dieting in obese subjects) and unvoluntary weight loss
(e.g. during cachexia in cancer patients).
AT refers to (i) the resting (or non-activity-related) compo-
nent of EE including resting energy expenditure (REE), as
well as the diet-induced thermogenesis (DIT), and (ii) non-
resting component (i.e. activity-related energy expenditure,
AEE, which is further divided into exercise and non-exercise
activity thermogenesis, EAT and NEAT) of total energy
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expenditure (TEE). Metabolically, AT has been explained by
the ratio of glycolytic to oxidative enzymes together with an
altered efficiency of free fatty acid oxidation in skeletal mus-
cle, Bfutile^ cycles consuming ATP without a net change in
products (e.g. hydrolysis of triglycerides and subsequent re-
esterification in adipocytes), changes in the ATP-costs per
muscle contraction, mitochondrial uncoupling in brown adi-
pose tissue, energy-consuming pathways like lipogenesis,
NEAT and/or partitioning of energy to fat mass or FFM [3].
These mechanisms are considered to be under genetic and
hormonal control, i.e. by insulin, leptin, thyroid hormones
and sympathetic nervous system (SNS) activity.
AT has been related to (i) negative energy balance due to
caloric restriction and/or excessive exercise, (ii) chronic over-
feeding, (iii) re-feeding after weight loss and (iv) weight main-
tenance after weight reduction. This will be discussed in
detail.
(i) With caloric restriction, negative energy balance and
weight loss cause decreases in all the energy expenditure com-
ponents, i.e. REE, DIT and AEE (for reviews see [3, 4]).
Sixty-five years ago, the Minnesota Starvation Experiment
was the first quantitative description of AT in humans [5••].
Since then, AT has been reproduced in experimental and clin-
ical studies on weight loss. AT varied between 100 and
500 kcal/day, it is observed in lean as well as overweight
subjects. AT is independent of the weight loss strategy.
(ii) In the 1968 Vermont overfeeding study, body weight
gain was lower than expected from the excess of energy intake
[6]. This had been explained by an increase in EE with over-
feeding as a dissipative mechanism to oppose weight gain.
The concept was in line with the Bgluttony^ concept proposed
byMiller et al. about 50 years ago [7, 8]. However, throughout
the following decades, numerous well-controlled studies
could not confirm mass-independent increases in REE and/
or DIT during chronic overfeeding (for reviews see [9–15]).
With continuous overfeeding, body energy stored was 60–
75 % of excess energy leaving the rest for an increase in EE
which was explained by obligatory costs (e.g. for gaining
body protein, increased cost of walking, etc. [9–11]. These
calculations left less than 10% of overfeeding-induced energy
expenditure unexplained which was accounted for errors of
methods and assumptions to estimate energy balance
questioning energy dissipation. However, during controlled
overfeeding, the non-resting component of EE, i.e. EAT in-
creases at unchanged NEAT [9, 16, 17]. This effect was inde-
pendent of weight gain-associated changes in body composi-
tion. Using a highly controlled protocol in lean subjects, in-
termittent periods of 3 weeks overfeeding at +20, +40 and
+60 % of energy needs at controlled and low physical activity
increased TEE, while again, there was no evidence for mech-
anisms able to dispose excess energy [18]. Macronutrient
composition may add to metabolic changes in response to
overfeeding. While there were no differences in increases in
EE after either carbohydrate or fat overfeeding [19], a high
protein intake may have a greater effect. Hypercaloric protein-
rich diets (with a protein content at 25 % of energy intake)
increased FFM, TEE and REE [20•]. However, AT was not
different between diets differing in protein content. This is
also against the idea that overfeeding low protein diets stimu-
lates thermogenesis [21]. Taken together, during overfeeding,
an adaptative increase in REE is non-existent and probably
more a measurement artefact [15, 18, 20•, 22]. By contrast, AT
seems to be related to the non-resting component of EE [9, 16,
17].
(iii) When recovering from starvation, people spontaneous-
ly overeat; body weight and fat mass increase. Weight regain
may be forced by persistence of the starvation-induced sup-
pression of thermogenesis [5••, 15, 22]. However, during a
controlled caloric restriction-refeeding cycle in healthy lean
men, mass-independent decreases in REE reversed within
2 weeks of refeeding [5••, 23••]. No energy dissipation oc-
curred with refeeding and weight regain.
(iv) If weight loss-induced AT persists during refeeding, it
may carry a long-term risk of Bovershooting^ pre-starvation
body weight and weight loss-weight regain cycles (for a re-
view see [17, 24–26, 27••, 28]). A low REE is a risk of weight
gain, and it impedes weight maintenance [26, 29]. The role of
AT in the control of weight loss maintenance has been ad-
dressed in a seminal series of controlled experiments per-
formed by Leibel and Rosenbaum (for reviews see [17, 24,
25•]). These authors investigated normal and overweight sub-
jects after a 10 or 20 % weight loss with a subsequently con-
trolled weight stabilisation phase of at least 14 days [17]. In
this protocol, AT was about 50 to 140 kcal/day and mainly
related to the non-REE component of TEE.
In a long-term observation study on weight-reduced over-
weight patients, weight regainers had a reduced AT when
compared with weight stable patients [26]. By contrast, after
massive weight loss of nearly 60 kg in severely obese patients,
weight regain was not associated with AT [27••]. The persis-
tence of AT during weight gain after weight loss has been
questioned by controlled feeding experiments [5••, 23••] and
computational modelling of human energy metabolism [30].
Following a starvation-refeeding cycle, the curve traced by
REE on FFM followed a loop with a decrease in the REE-
FFM association induced by negative energy balance and a
nearly parallel increase during refeeding: At a similar FFM,
REE was lower after 12 weeks of starvation when compared
with 12 weeks of refeeding [30].
Weight change-associated changes in EE vary among indi-
viduals but may be related to one another within individuals
responding to weight gain and weight loss [31, 32]. With
negative energy balance, a high AT reduces the drive towards
weight loss. By contrast, a low AT in response to overfeeding
increases the metabolic drive to gain weight. In a given indi-
vidual, both mechanisms add to efficient energy use to
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conserve body energy providing a so-called thrifty phenotype
[32, 33]. Vice versa, a low AT in response to negative energy
balance together with a high AT during positive energy bal-
ance favours weight loss during caloric restriction and limits
weight gain with overfeeding altogether characterising a so-
called spendthrift phenotype [32, 33]. Over long-term, meta-
bolic phenotypes characterised by AT are correlated to subse-
quent weight changes.
Based on the quantitative physiology of weight change,
robust mathematical (so-called Bflux-balance^) models of hu-
man energy metabolism and AT have been developed and
validated [30, 34•, 35]. Crucial points of these models relate
to (i) energy partitioning (i.e. energy imbalance is divided
between fat mass and FFM) and (ii) possible feedbacks of
fat mass and/or FFM on energy intake which are assumed to
be constant. Computational modelling is now widely used to
predict weight changes in obese patients during dieting or to
explain the non-linear function of weight loss.
Taken together, the present data suggest an asymmetry in
AT of the resting component of EE in response to changes in
energy balance. While there is no adaptation in the REE com-
ponent of EE in response to over-feeding and refeeding, REE-
related AT refers to weight loss only. In addition, adaptation in
the non-resting component of EE relates to maintenance of
reduced body weight as well as possible energy dissipation
with overfeeding. During negative energy balance AT results
from a compensatory feedback directed towards conservation
of energy and limitation of weight loss. AT has been related to
biology of body weight regulation and is a possible Bre-set^ of
defence. From a clinical standpoint, AT is seen as a metabolic
vulnerability of obese patients.
New and Interesting Findings
AT seems to be well-established in the biology of weight loss.
Presently, there are three innovative topics related to AT in
humans: first, definition and assessment of AT; second, the
dynamics of metabolic adaptation related to weight loss and
weight loss maintenance; and third, the determinants of AT.
Definition and Assessment of AT
Following Ancel Keyes original definition [5••], AT refers to
changes in REE which are independent from FFM and FFM
composition. During weight loss, AT reflects decreases in spe-
cific metabolic rates of organs and tissues within FFM. It
follows that AT can only be assessed based on accurate body
composition analysis (BCA) including magnetic resonance
imaging (MRI) to quantitate masses of low (i.e. skeletal mus-
cle) and high metabolic rate organs (i.e. brain, liver, heart and
kidneys) [3, 36, 37••]. After adjustment of REE for FFM, only
ATwas calculated to be around 100 kcal/day (or about 50% of
the fall in REE; 23). In that study, FFM decreased by 2.4 kg
with concomitant changes in the masses of skeletal muscle
(−1.5 kg) and liver (−0.2 kg) [23••]. Adjusting REE for chang-
es in FFM plus the anatomical composition of FFM, Btrue^
AT was calculated to be 70 kcal/day [23••]. It is tempting to
speculate that additional adjustments of REE for the molecular
composition of organs and tissues (e.g. for their hydration,
protein content and density) will further affect the calculation
of AT [36].
Normalising REE for FFM or FFM+ fat mass has limita-
tions when one addresses changes in REE with weight loss.
Normalisation is a statistical approach. It does not take into
account physiological changes in adipose tissue-derived FFM
(water, protein, minerals in adipocytes), the proportion of the
high metabolically active organs and tissues to FFM (see
above) and a yet poorly defined thermic effect of adipocytes
probably due to their secretory and inflammatory activities [3,
37••]. The characteristics of regressions for FFM and fat mass
differ between different degrees of adiposity [37••, 38]. In fact,
applying the REE on FFM+ FM-relationship before weight
loss to data obtained after a 6-kg weight loss led to an error of
about 70 kcal/day. The overestimation of AT calculated from
the REE vs FFM + FM relationship before weight loss
increases after a 50-kg weight loss in severely obese subjects
explaining (but also questioning) a magnitude of AT of about
300 kcal/day at a decrease in REE of about 600 kcal/day [39].
By contrast, using a %fat mass-specific regression equation to
normalise REE before and after weight loss reduced AT to
120 kcal/day [37••].
AT can be calculated from the difference between REE
adjusted for FFM + fat mass before and after weight loss.
Alternatively, the difference between measured REE and
REE calculated from organ and tissue masses times their spe-
cific metabolic rates can be used [23••, 37••, 40, 41]. This
difference is a measure of the mass-independent changes in
energy expenditure, and it increases after weight loss.
However, the approach depends on some assumptions, e.g.
regarding the molecular composition of organs and tissues
and their specific metabolic rates. Since 3 days of caloric
restriction may result in losses of up to 2–3-l water with an
accompanying 3.6 % change in FFM hydration [36], a weight
loss-associated change in FFM does not necessarily reflect a
decrease in metabolically active FFM. Overestimating the loss
of metabolically active FFM results in an underestimation of
AT [22, 36]. In addition, specific metabolic rates of individual
organs and tissues are not constant but vary with adolescence,
age above 55 years, obesity, weight change and work load [41,
42].
There is need of more sophisticated concepts to assess AT.
Presently, detailed BCA at the organ-tissue level (using whole
body MRI to assess organ and tissue masses) together with
BCA at the molecular level (using balance and dilution
Curr Obes Rep (2016) 5:413–423 415
techniques to assess changes in tissue hydration and protein
content) is needed for proper adjustments of REE. In addition,
direct estimates of specific metabolic rates of organs and tis-
sues by magnetic resonance spectroscopy and/or positron
emission tomography (PET) will add to assess functional
body composition and AT. Faced with these conceptual and
methodological caveats, AT cannot be considered as a biolog-
ical entity. In addition, scientists should be honest about the
limits of detection using state-of-the-art technologies to assess
EE [22, 43]. The precision differs between assessments of
REE by indirect calorimetry (between 1 and 3 %) and mea-
surements of TEE with doubly labelled water (DLW, above
5%) where the intra-individual variance may exceed the inter-
individual variance [22].
Dynamics of Metabolic Adaptation Related
to Weight Loss and Weight Loss Maintenance
Changes in energy expenditure are functions of time with
fluctuations within minutes, hours, days, weeks and months.
In the Minnesota Starvation Experiment, REE and body com-
position were measured after 1, 3 and 6 months of caloric
restriction [5••]. This time scale is in line with more recent
clinical studies on AT which vary in observation periods be-
tween 3 weeks and 6 years ([1, 27••, 44–49]; for reviews see
[3, 4, 50]). Weight loss results from a negative energy balance
and changes in body composition; it is not continuous but
curve-linear ending when a new steady state and, thus, a
new equilibrium between energy intake and energy expendi-
ture are reached [51].
During caloric restriction, the first phase of weight loss is
rapid and lasts less than a week (phase 1); this is followed by a
second phase characterised by a slower weight loss (=late
phase) [51]. With total starvation, phase 2 continues until fat
mass is nearly completely depleted. Weight loss becomes del-
eterious to the subject when body protein is the only endoge-
nous energy source left. During controlled 3-week semi-star-
vation, healthy young men lost about 3.2 kg during week 1
and 1.3 to 1.4 kg/week during week 2 and 3 [23••, 36, 40].
Decay constants in weight were calculated as K1 = −0.78 kg/
day (week 1 = phase 1) and K2 = −0.19 kg/day (week 2 and
3 = phase 2). As to body composition, the corresponding de-
creases in FFMwere 313, 90 and 66 g/day, respectively [23••].
Concomitantly, fat mass decreased by 168, 109 and 142 g/day.
Weight loss is characterised by defined changes in body
composition. These changes relate to AT. During phase 1,
decreases in FFM exceed the decrease in fat mass; they are
due to losses in intracellular (due to glycogen and protein
mobilisation) and extracellular water (due to an increase in
natriuresis) rather than to losses in cell mass per se [23••,
36]. By contrast, phase 2 relates more to the steady and ongo-
ing loss of fat mass. Since the energy content per kilogram
change differs between body fat (i.e. 9434 kcal) and FFM (i.e.
1815 kcal), the composition of weight lost is the main deter-
minant of weight changes in response to a given energy bal-
ance [34•, 35, 51].While decreases in fat mass explained 34%
of weight loss during phase 1, this proportion increased to 64
and 68 % during phase 2. Thus, the energy content per kilo-
gram weight change increased from 4409 kcal during phase 1
to 5209 and 7105 kcal during phase 2 [23••].
Obviously, assessment of AT must follow the dynamics of
weight loss. EE should be measured longitudinally before and
during the two different phases of weight loss. Unfortunately,
this idea has not been addressed in nearly all of the above-
mentioned clinical studies on AT where EE had been mea-
sured before and after weeks or even after months or after
years of weight loss only. During controlled caloric restriction,
AT becomes manifest within the first 3 days with no further
changes during phase 2 [23••, 40]. This is evidence for the
idea that regulation of AT occurs during phase 1. By contrast,
the decrease in REE closely followed weight loss during
phase 2 (i.e. there was no further mass-independent adaptation
in REE). Faced with these dynamics clinical investigations
cited above did not address the regulation of AT. All the
worse, many clinical studies on weight loss are metabolically
uncontrolled, i.e. it remains unclear whether weight-reduced
patients have reached a weight stable state or whether they are
still losing or already regaining body weight.
Determinants of AT
AT is considered as an outcome of autoregulatory control that
operates to limit weight loss and to restore body composition
[3, 14, 22, 52, 53]. During weight loss, there is a considerable
inter-individual variance in AT [3, 23••, 44, 54•] (Fig. 1).
Taking into account the precision of indirect calorimetry, up
to 60 % of subjects experienced a greater-than-expected de-
cline in REE after weight loss [3, 23••]. On the other hand, AT
was found to be reproducible [23••]. Thus, AT is considered as
an individualised trait.
AT was independent of macronutrient composition of the
diet [44–47]. It was thought to be proportional to the degree of
weight loss with an additional effect of baseline weight [47].
However, analysing data on obese patients before and after
weight loss [1, 55, 56], the association between weight change
and ATwas weak (see Fig. 2). This was in line with the results
of a controlled clinical study on obese patients using total
starvation or different hypocaloric diets for weight loss [48].
By contrast, the starvation-induced fall in REE was closely
related to REE before weight loss: The higher baseline REE
was, the higher was AT [23••].
In addition, there is an association between AT of the non-
REE component of EE and maintenance of reduced body
weight [24, 25•, 52]. Most of AT occurred during weight
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maintenance after a moderate weight loss of −10 % with
smaller additional effects induced by a weight loss of −20 %
[17, 52]. Recently, Rosenbaum and Leibel proposed three
models of AT during weight maintenance [25•]: Model 1, no
AT, i.e. a Bmechanical model^ related to settling of body
weight; model 2, fixed AT due to a threshold response (model
2) and model 3, AT is proportional to weight loss. With initial
weight loss, both REE and AEE decreased by a fixed amount
of kilocalories. This was independent of changes in body com-
position. With further weight loss, only AEE continued to
decrease. Thus, AT related to the resting compartment of
TEE followed the threshold model, whereas AT in the non-
resting compartment of TEE is proportional to weight loss
[25•].
Determinants of AT have to be discussed in the contexts of
(i) weight loss and (ii) maintenance of reduced weight.
Weight Loss
Regulation of AT has been related to changes in the compo-
sition of FFM (i.e. a change in the proportion of high meta-
bolic rate organs to muscle mass as well as tissue hydration),
reduced endocrine signals from triiodothyronine (T3), insulin
and SNS activity and/or a reduced feedback from adipocytes
brought about by a fall in leptin secretion.
In a clinical study, obese women lost a mean of 9.5 kg body
weight with an AT of 112 kcal [55]. Concomitantly, the rela-
tive loss of high metabolic rate organ masses was significantly
Fig. 1 Inter-individual variances in the resting (=ΔREEadj FFM) and non-
resting compartment (ΔAEEadj FFM) of adaptive thermogenesis (AT)
during controlled 3 weeks under-feeding (at −50 % of energy
requirements in green) and 2 weeks re-feeding (at +50 % of energy
needs in red) protocol in 31 healthy and normal weight young men. For
original data see ref 23. The subjects were ranked according their REE
before intervention (upper panel). After adjustment for FFM, there were
no interindividual differences in REE measured before the weight cycle.
Mean group changes with weight loss and weight gain are given on the
right side of the figure. AT occurred at underfeeding only. REE resting
energy expenditure, AEE activity-related energy expenditure, FFM fat
free mass (colour figure online)
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higher than was the change in low metabolically active parts
of FFM [55]. Changes in FFM composition explained about
50 % of AT. Comparing patients with high vs low AT, the
former better conserved liver and kidney masses with weight
loss [55]. During controlled underfeeding, AT was 108 kcal;
36 kcal was explained by changes in FFM composition [23••].
There were no associations between AT and changes in fat
mass or regional fat depots [23••, 55].
Although fat mass, plasma levels of leptin, leptin per fat
mass and T3 as well as SNS activity all decreased with neg-
ative energy balance and weight loss, neither their levels nor
their changes were associated with AT [23••]. In severely
obese subjects who had lost about 40 % of their body weight,
both the decreases in plasma leptin levels and REE exceeded
the loss in body weight, but no associations were detected
between changes in EE, and changes in leptin concentration
[39]. Although some authors have found some correlations
between the weight loss-associated decreases in plasma leptin
levels and AT, leptin explained 6 % of the variance in ATonly
[49, 57]. Investigating AT up to 12 months after bariatric sur-
gery with a group mean weight loss of 44 kg showed that
metabolic adaptation correlated with changes in insulin,
adiponectin, leptin, T3, gut hormones and SNS activity [47].
By contrast, there was no correlation between ATand changes
in plasma leptin levels in the participants of the BBiggest
Looser Competition^ with mean AT of 275 kcal/day after
7.5 months and 499 kcal/day after 6 years and concomitant
loss and regain of fat mass of −47.2 and +35.2 kg, respectively
[27••]. Concomitantly, plasma leptin levels decreased and in-
creased by −38.6 and +25.12 ng/ml.
In addition, there were no associations between AT and the
weight loss-associated decrease in circulatory T3 [23••, 27••]
and SNS activity [23••]. This is not against the findings that
low-dose T3 or catecholamine replacements increase REE [58,
59]. However, a drug replacement protocol may not resemble
physiological regulation. In fact, pharmacological inhibition of
endogenous production of T3 in isocalorically fed subjects was
without effect on energy expenditure [60]. Taken together, lep-
tin, T3 and SNS-activity seem to be unrelated to AT.
Since regulation of AT occurred during phase 1 of weight
loss, one has to address its possible determinants within this
period. During phase 1, ATwas associated with the starvation-
induced fall in insulin secretion, low RQ, negative fluid bal-
ance with losses in intracellular to extracellular water and a
low free water clearance rate (FWCR; [23••]). Depletion of
hepatic glycogen stores, losses in ICW and ECW (due to in-
creased natriuresis) all relate to the starvation-induced fall in
plasma insulin concentrations [61, 62]. Whole body RQ de-
creased by 8 or 11% in response to semistarvation or total fast,
respectively [23••, 62]. Within 3 days of total fast, the rate of
hepatic glycogenolysis decreased by 93 % with a related de-
crease in total liver glycogen content from 373 to 47 mmol
[62]. This resulted a decrease in liver volume by 370 ml with
fasting [62] compared with 150 ml during semistarvation
[23••]. Concomitantly, whole body fluid balance became neg-
ative by 570 ml/week [23••]. The lower insulin secretion was,
the lower FWCR was. A low insulin secretion and a reduced
FWCR were both associated with a high AT and vice versa.
By contrast, there were no associations between AT and
changes in urinary 24-h sodium and aldosterone excretion as
well as plasma levels of natriuretic peptides [23••].
AT was associated with starvation-induced decreases in
body temperature, heart rate and glomerular filtration rate
[23••] suggesting that AT is part of the concerted physiological
response to weight loss with the fall in insulin secretion as its
major characteristic. This is in line with clinical data that high
AT correlated with the decrease in plasma insulin levels [55].
During phase 1, AT is explained by Bthresholdmodel^ related
to the fall in insulin secretion [25•, 40]. During phase 2, there is
no additional effect of ongoing weight loss on the REE-FFM
regression line. This is evidence for a Bmechanical model^ [25•].
Weight Loss Maintenance
During maintenance of reduced body weight, TEE remained
reduced [24]. This relates to AT in the non-resting component
of EE; it is accompanied by increased skeletal muscle work
efficiency, decreased plasma levels of leptin and T3 associated
with low SNS activity [23••, 63]. Decreases in fat mass were
related to changes in TEE [24, 25•, 52, 57]. This is in line with
the concept that after weight loss AT is a direct function of body
fat depletion [28]. The loss in fat mass then generates the fall in
plasma leptin concentrations which is related to AT. In fact,
replacing leptin duringmaintenance of reduced weight reversed
two-thirds of the fall in TEE and AEE while increasing work
efficiency in skeletal muscle [64, 65•]. When compared to a
placebo-treated group, TEE adjusted for FFM (but not REE)
Fig. 2 Association between adaptive thermogenesis and weight loss in
151 overweight patients after dietary or bariatric surgery-induced weight
loss. Data from refs 1, 55, and 56
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was significantly greater in Bleptin-treated 10 % weight-
reduced weight-maintained patients^ suggesting that higher
leptin levels promote weight loss [65•]. Leptin replacement
reversed the neuroendocrine adaptations and increased in plas-
ma T3 levels and SNS activity suggesting that the non-resting
component-related part of AT is under endocrine control.
Adaptation of AEE follows the dynamics of weight loss and
thus supports model 3 of energy homeostasis [25•]. It should be
mentioned that controlling body weight after gradual weight
loss (as done in ref) [17, 64, 65•] does not follow a physiolog-
ical response but may interfere with biology. This situation may
be considered as an exogenously Bforced^ regulation.
One of the caveats of the adipocentric view of AT is that
leptin itself had no effect on EE in leptin deficient or over-
weight patients. Giving recombinant leptin to children with
congenital leptin deficiency (an extreme situation producing
a severely obese phenotype), for weight loss in obese patients
or for weight maintenance in obese patients after gastric by-
pass surgery was without effect on TEE and REE [66–69]. By
contrast, leptin replacement in patients with generalised
lipodystrophy (characterised by the absence of subcutaneous
fat, fatty liver and marked hypoleptinemia which is again an
extreme phenotype) decreased rather than increased REEwith
relatively minor decreases in body weight [70].
In population studies on subjects differing in body weight,
normal or elevated plasma leptin levels did not correlate with
energy expenditure [71, 72]. By contrast, there was a close
association between very low leptin levels and REE in severe-
ly underweight patients with anorexia nervosa; this associa-
tion disappeared again during treatment, i.e. with increases in
fat mass and plasma leptin concentrations [71]. These obser-
vations fit to the idea of an asymmetric leptin physiology [63,
73]: Leptin has no thermogenic effect at normal or high con-
centrations, whereas the effect becomes apparent after leptin
levels fall below a threshold level invoking a mass-
independent decrease in EE. This threshold may reflect a min-
imum level of fat mass needed for biological functioning.
However, when compared with underweight anorectic
women, weight loosing obese patients or even normal weight
men are unlikely to reach the minimum threshold of fat mass
and/or leptin levels. Accordingly, an alternative threshold shift
paradigm has been proposed for obese patients [63, 74].
Comparing the association between BMI and plasma leptin
levels in 110 patients undergoing bariatric surgery, the slope of
the relation was flatter after surgery. The authors took this as
evidence for a weight threshold which may trigger the leptin
response to defend body weight. Energy expenditure was not
measured in that study, but the idea of a shift to an elevated
threshold has also been proposed for obese compared to nor-
mal weight subjects to explain their defences of higher fat
stores [74, 75•].
Taken together, there was no thermogenic effect of leptin in
subjects at usual weight and during weight loss. By contrast,
an effect of exogenous leptin administration was seen in
weight-stable-weight-reduced subjects only [64, 75•]. To
reach weight maintenance, leptin was substituted to the pre-
weight loss plasma level. Thus, with replacement circulating
leptin probably increased from values below to above the
individual thresholds waning the effect of leptin on energy
expenditure and energy balance. Leptin thresholds may differ
between different metabolic functions (e.g. for energy intake
vs energy expenditure) [75•] and may also relate to thresholds
of other hormone-function relationships being part of the con-
certed neuroendocrine responses to negative energy balance,
weight loss and weight maintenance. These thresholds are
considered as individualised traits adding to the variance in
AT as well as long-term weight changes [25•].
Conclusions: A Proposed Concept and a Future
Perspective
With weight loss, AT has to be differentiated in relation to (i) the
individual component of TEE, (ii) different phases of weight loss
and (iii) weight loss maintenance. The first issue is about resting
and non-resting EE. The second is about hepatic glycogen
mobilisation andmass-independent sparing energywith negative
energy balance. The third issue relates to a possible Breset^ of the
biological defence of body weight after weight loss and thus the
risk of weight regain. Figure 3 surveys metabolic adaptation to
weight loss and weight maintenance and their determinants with
time.We propose to differentiate between three phases of weight
loss addressing two different regulatory systems. The first is the
immediate control of metabolism in response to negative energy
balance (phase 1), whereas the second regulatory system impacts
weight maintenance after weight reduction (phase 3). Between
the two regulations (i.e. during phase 2), changes in EE are
proportional to weight change, and there is no further increase
in ATwith ongoing weight loss.
During negative energy balance, mitochondrial carbon load
decreases and ATP demand is met by the mobilisation of en-
dogenous sources, i.e. glycogen and triglycerides. Losses in
functional body mass and AT add to reduce ATP demand.
Metabolically, the paramount characteristic of phase 1 is the
depletion of glycogen stores, whereas in phase 3, AT is trig-
gered by the loss in body fat. As far as set points (i.e. feedback
systems designed to match a target) and settling points (i.e.
control systems without a set point) in body weight regulation
are concerned [76, 77], the data give rise to the idea that (i) AT
is part of body weight regulation and (ii) there are two set
pointswith a settling between them. The first set point is about
the decrease in glycogen stores only. We assume that in early
starvation, lower thresholds of (i) liver glycogen or (ii) nega-
tive fluid balance associated with glycogen depletion trigger
AT. It is tempting to speculate that this early response is related
to energy needs of the brain (i.e. brains metabolism requires
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80 to 100 g glucose per day). By contrast, AT does not occur
after glycogen depletion in response to an isocaloric ketogenic
diet and moderate weight loss [78]. This may be explained by
concomitant increases in plasma ketones providing an alter-
native fuel to the brain and, thus, put the glycogen threshold
into perspective. During weight maintenance, a lower margin
of the leptin-fat mass-association is the second set point keep-
ing energy expenditure low to prevent triglyceride stores get-
ting too low which again would limit basic biological func-
tions (e.g. reproduction).
Future biomedical research on the physiology, genetics, cel-
lular and/or molecular aspects of body weight regulation and AT
needs robust concepts taking into account conceptual issues, ad-
vanced methodological approaches, the dynamics of weight
change and in depth physical and metabolic phenotyping. We
still lack an integrated understanding of AT. It is also
worthwhile to remember that our present knowledge
about AT in humans is based on a small number of con-
trolled experimental studies (including the nearly 70 years
old Minnesota Starvation Experiment; 5) as well as a
greater number of more or less uncontrolled clinical ob-
servations. Both approaches do not address the Breal^
physiology of weight changes which may take several
years to obtain a new steady body weight [79].
Acknowledgments Our own research was supported by grants of the
GermanMinistry of Education and Research (BMBF 01EA1336; BMBF
Kompetenznetz Adipositas Core Domain Body Composition,
Körperzusammensetzung 01G1125), the German Research Foundation
(DFG Mü 714/8-3 and DFG Bo 3296 1–1).
Fig. 3 Overview about metabolic adaptation with weight loss and during
maintenance of reduced body weight. During the first week of caloric
restriction, adaptive thermogenesis (AT) relates to the resting component
of energy expenditure (REE) and follows the depletion of hepatic
glycogen stores due to the immediate fall in insulin secretion.
Mobilisation of glycogen is associated with changes in fluid balance
and fat free mass. AT is seen as an immediate adaptation to negative
energy balance as part of body weight regulation according to a set
point. With ongoing underfeeding and weight loss, phase 2 is
characterised by a loss of fat mass which follows the negative energy
balance up to a settling point where a new steady state is reached. Then,
maintenance of reduced body weight (phase 3) is due the degree of
reduced fat mass and low leptin levels associated with a low T3 state
and low SNS activity. This endocrine pattern carries the risk of weight
regain. The inserted graph on the right shows that during phase 1, AT is
characterised by an adaptation of the resting component of energy
expenditure. This is maintained throughout further weight loss and
during successful maintenance of reduced body weight. By contrast,
adaptation in the non-resting component of energy expenditure (nREE)
is proportional to weight loss. Up to now, early changes in nREE have not
been investigated, and data are available after 3 weeks of semistarvation
only [23]. FFM fat free mass; ICW intracellular water; ECW extracellular
water; FM fat mass; OM masses of high metabolically active
organs = sum of masses of brain, heart, liver, and kidneys; MM skeletal
muscle mass; FFA free fatty acids; T3 tri-iodothyronine; SNS sympathetic
nervous system activity; NP natriuretic peptides; Gluc-ox glucose
oxidation rate; lip-ox lipid oxidation rate; prot-ox protein oxidation rate.
See text for further details and references
420 Curr Obes Rep (2016) 5:413–423
Compliance with Ethical Standards
Conflict of Interest Manfred J. Müller is a consultant of Seca GmbH
(Hamburg, Germany).
Janna Enderle declares that she has no conflict of interest.
Anja Bosy-Westphal declares that she has no conflict of interest.
Human and Animal Rights and Informed Consent This article does
not contain any studies with human or animal subjects performed by any
of the authors.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted
use, distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
References
Papers of particular interest, published recently, have been
highlighted as:
• Of importance
•• Of major importance
1. Goele K, Bosy-Westphal A, Rumcker B, Lagerpusch M, Müller
MJ. Influence of changes in body composition and adaptive ther-
mogenesis on the difference between measured and predicted
weight loss in obese women. Obes Facts. 2009;2:105–9.
2. Byrne NM, Wood RE, Schutz Y, Hills AP. Does metabolic com-
pensation explain the majority of less-than-expected weight loss in
obese adults during a short-term severe diet and exercise interven-
tion? Int J Obes. 2012;36:1472–8.
3. Müller MJ, Bosy-Westphal A. Adaptive thermogenesis with weight
loss in humans. Obesity. 2013;21:218–28.
4. Browning MG, Franco RL, Cyrus JC, Celi F, Evans RK. Changes
in resting energy expenditure in relation to body weight and com-
position following gastric restriction: a systematic review. Obes
Surg. 2016;26:1607–16.
5.•• Keys A, Brozek J, Henschel A, Mickelen O, Taylor HL. The biol-
ogy of human starvation. Minneapolis (Mn): The University of
Minnesota Press; 1950. This is the first quantitative study on
adaptive thermogenesis in humans.
6. Sims EAH, Goldman RF, Gluck CM, Horton ES, Kelleher PC,
Rowe DW. Experimental obesity in man. Trans Assoc Am
Physicians. 1968;81:153–69.
7. Miller DS, Mumford P. Gluttony. 1. An experimental study of
overeating low- and high protein diest. Am J Clin Nutr.
1967;20:1212–22.
8. Miller DS, Mumford P, Stock MJ. Gluttony.2.Thermogenesis in
overeating man. Am J Clin Nutr. 1967;20:1223–9.
9. Tremblay A, Depres J-P, Theriault G, Fournier G, Bouchard C.
Overfeeding and energy expenditure in humans. Am J Clin Nutr.
1992;56:857–62.
10. Diaz EO, Prentice AM, Goldberg GR, Murgatroyd PR, Coward
WA. Metabolic response to experimental overfeeding in lean and
overweight healthy volunteers. Am J Clin Nutr. 1992;56:641–55.
11. Ravussin E, Schutz Y, Acheson KJ, DusmetM, Bourquin L, Jequier
E. Short-term, mixed diet overfeeding in man. No evidence for
Bluxuskonsumption^. Am J Physiol Endocrin Meta. 1985;249:
E470–7.
12. Freymond D, Larson K, Bogardus C, Ravussin E. Energy expendi-
ture during normo- and overfeeding in peripubertal children of lean
and obese Pima Indians. Am J Physiol Endocrin Metab. 1989;257:
E647–53.
13. Roberts S, Young VR, Fuss P, Fiatarone MA, Richard B,
Rasmussen H, et al. Energy expenditure and subsequent nutrient
intakes in overfed young men. Am J Physiol Reg Integ Comp
Physiol. 1990;259:R461–9.
14. Saltzman E, Roberts SB. The role of energy expenditure in energy
regulation: findings from a decade of research. Nutr Rev. 1995;53:
209–20.
15. Westerterp KR. Metabolic adaptations to over- and underfeeding –
still a matter of debate? Eur J Clin Nutr. 2013;67:443–5.
16. Apolzan JW, Bray GA, Smith SR, de Jonge L, Rood J, Han H, et al.
Effects of weight gain induced by controlled overfeeding on physical
activity. Am J Physiol Endocrin Metab. 2014;307:E1030–1037.
17. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure
resulting from altered body weight. N Engl J Med. 1995;332:621–8.
18. Siervo M, Frühbeck G, Dixon A, Goldberg GR, Coward WA,
Murgatroyd PR, et al. Efficiency of autoregulatory homeostatic
responses to imposed calorie excess in lean men. Am J Physiol
Endocrinol Metab. 2008;294:E416–24.
19. Lammert O, Grunnet N, Faber P, Schroll Bjoernsbo K, Dich J, Larsen
LO, et al. Quistorff. Effects of ioenergetic overfeeding with either
carbohydrates or fat in young men. Br J Nutr. 2000;84:233–45.
20.• Bray GA, Redman LM, de Jonge L, Covington J, Rood J, Brock C,
et al. Effect of protein overfeeding on energy expenditure measured
in a metabolic chamber. Am J Clin Nutr. 2015;101:496–505. The
authors showed that continuously overfeeding a protein-rich
diet has no energy disspating effect. This is contrary to the
immediate diet-induced thermogenesis which is higher after a
protein-rich meal when compared to meals rich in either car-
bohydrates or fat.
21. Stock MJ. Gluttony and thermogenesis revisited. Int J Obes.
1999;23:1105–17.
22. Dulloo AG, Jaquet J, Montani JP, Schutz Y. Adaptive thermogen-
esis in human body weight regulation:more a concept than a mea-
surable entity. Obes Rev. 2012;13(Suppl2):105–21.
23.•• Müller MJ, Enderle J, Pourhassan M, Braun W, Eggeling B,
Lagerpusch M, et al. Metabolic adaptation to caloric restriction
and subsequent refeeding: the Minnesota Starvation Experiment
revisited. Am J Clin Nutr. 2015;102:807–19.This is the first study
addressing the kinetics of adaptive thermogenesis.
24. Rosenbaum M, Hirsch J, Gallagher DA, Leibel RL. Long-term
persistence of adaptive thermogenesis in subjects who have main-
tained a reduced body weight. Am J Clin Nutr. 2008;88:906–12.
25.• Rosenbaum M, Leibel RL. Models of energy homeostasis in re-
sponse to maintenance of reduced body weight. Obesity. 2016;24:
1620–9. This study adds much to the conceptual issue since it is
first in modelling metabolic adaptation to weight loss and
weight maintenance.
26. Bosy-Westphal A, Schautz B, Lagerpusch M, Pourhassan M, Braun
W, Goele K, et al. Effect of weight loss and regain on adipose tissue
distribution, composition of leanmass and resting energy expenditure
in young overweight and obese adults. Int J Obes. 2013;37:1371–7.
27.•• Fothergill E, Guo J, Howard L, Kerns JC, Knuth ND, Brychta R,
et al. Persistent metabolic adaptation 6 years after "The Biggest
Loser" competition. Obesity. 2016;24:1612–9. This study reached
public attention and was heavily broadcasted by the media as
an example of disturbed metabolism after severe weight loss as
a cause for weight regain.
28. Dulloo AG, Jaquet J, Girardier L. Autoregulation of body compo-
sition during weight recovery in humans: the Minnesota
Experiment revisited. Int J Obes. 1996;20:393–405.
Curr Obes Rep (2016) 5:413–423 421
29. Ravussin E, Lillioja S, Knowler WC, Christin L, Freymond D,
Abbott WG, et al. Reduced rate of energy expenditure as a risk
factor for body-weight gain. N Engl J Med. 1988;25(318):467–72.
30. Hall KD. Computational model of in vivo human energy metabo-
lism during semistarvation and refeeding. Am J Physiol Endocrinol
Metab. 2006;291:E23–37.
31. Weyer C, Pratley RR, Salbe AD, Bogardus C, Ravussin E,
Tataranni PA. Energy expenditure, fat oxidation, and body weight
regulation: a study of metabolic adaptation to long term weight
change. J Clin Endocrin Metab. 2000;85:1087–94.
32. Reinhardt M, Thearle MS, Ibrahim M, Hohenadel MG, Bogardus
C, Krakoff J, et al. A human thrifty phenotype associated with less
weight loss during caloric restriction. Diabetes. 2015;64:2859–67.
33. Schlögl M, Piaggi P, Pannacciuli N, Bonfiglio SM, Krakoff J,
Thearle MS. Energy expenditure responses to fasting and overfeed-
ing identify phenotypes associated with weight change. Diabetes.
2015;64:3680–9.
34.• Hall KD, Sacks G, Chandramohan D, Chow CC, Wang YC,
Gortmaker SL, et al. Quantification of the effect of energy imbal-
ance on bodyweight. Lancet. 2011;378:826–37. The authors had
included adaptive thermogenesis to predict weight changes in
overweight patients. That computer program is now widely
used in science as well as in clinical practice to predict and thus
to control outcomes (i.e. weight changes).
35. Chow CC, Hall KD. The dynamics of human body weight change.
PLoS Comput Biol. 2008;4(3):e1000045.
36. Müller MJ, Bosy-Westphal A. Methodologic considerations in the
evaluation of adaptive thermogenesis. Reply to MG Browning. Am
J Clin Nutr. 2016;103:953–4.
37.•• Bosy-Westphal A, Braun W, Schautz B, Müller MJ. Issues charac-
terizing resting energy expenditure in obesity and after weight loss.
Front Physiol. 2013;4:47. doi:10.3389/fphys.2013.00047. 1–9 This
is a fundamental paper on suitable adjustments of energy
expenditure which is the basis to assess adaptive
thermogernesis.
38. Bosy-Westphal A, Müller MJ, Boschmann M, Klaus S, Kreymann
G, Lührmann PM, et al. Grade of adiposity affects the impact of fat
mass on resting energy expenditure in women. Br J Nutr. 2009;101:
474–7.
39. Johannsen DL, Knuth ND, Huizenga R, Rood JC, Ravussin E, Hall
KD. Metabolic slowing with massive weight loss despite preserva-
tion of fat free mass. J Clin Endocrin Metab. 2012;97:2489–96.
40. Müller MJ. Adaptive thermogenesis: do we need new thinking?
Obesity. 2016;24:160–1611.
41. Müller MJ, Wang Z, Heymsfield SB, Schautz B, Bosy-Westphal A.
Advances in the understanding of specific metabolic rates of major
organs and tissues in humans. Curr Opin Clin Nutr Metab Care.
2013;16:501–8.
42. Pourhassan M, Eggeling B, Schautz B, Johannsen M, Kiosz D,
Glüer CC, et al. Relationship between submaximal oxygen uptake,
detailed body composition, and resting energy expenditure in over-
weight subjects. Am J Hum Biol. 2015;27:397–406.
43. Bader N, Bosy-Westphal A, Dilba B, Müller MJ. Intra- and inter-
individual variability of resting energy expenditure in healthy male
subjects – biological and methodological variability of resting en-
ergy expenditure. Br J Nutr. 2005;94:843–9.
44. Ebbeling CB, Swain JF, Feldman HA, Wong WW, Hachey DL,
Garcia-Lago E, et al. Effects of dietary composition on energy
expenditure during weight loss maintenance. JAMA. 2012;307:
2627–34.
45. De Jonge L, Bray GA, Smith SR, Ryan DH, de Souza RJ, Loria
CM, et al. Effect of diet composition and weight loss on resting
energy expenditure in the POUNDS LOSTstudy. Obesity. 2012;20:
2384–9.
46. Racette SB, Schoeller DA, Kushner RF, Neil KM, Herling-
Iaffaldano K. Effects of aerobic exercise and dietary carbohydrate
on energy expenditure and body composition during weight reduc-
tion in obese women. Am J Clin Nutr. 1995;61:486–94.
47. Butte N, Brandt ML, Wong WW, Liu Y, Mehta NR, Wilson TA,
et al. Energetic adaptations persist after bariatric surgery in severely
obese adolescents. Obesity. 2015;23:591–601.
48. Siervo M, Faber P, Lara J, Gibney ER, Milne E, Ritz P, et al.
Imposed rate and extent of weight loss in obese maen and adaptive
changes in resting and total energy expenditure. Metabolism.
2015;64:896–904.
49. Camps SGJA, Verhoef SPM, Westerterp KR. Leptin and energy
restricition induced adaptation in energy expenditure. Metabolism.
2015;64:1284–90.
50. Schwartz A, Kuk JL, Lamothe G, Doucet E. Greater than predicted
decrease in resting energy expenditure and weight loss: results from
a systematic review. Obesity. 2012;20:2307–10.
51. Heymsfield SB, Thomas D, Nguyen AM, Peng JZ, Martin C, Shen
W, et al. Voluntary weight loss: systematic review of early phase
body composition changes. Obes Rev. 2011;12:e348–61.
52. Rosenbaum M, Leibel RL. Adaptive thermogenesis in humans. Int
J Obes. 2010;34 Suppl 1:S47–55.
53. Dulloo AG. Suppressed thermogenesis as a cause for resistance to
slimming and obesity rebound: adaptation or illusion? Int J Obes.
2007;31:201–3.
54.• Hopkins M, Gibbons C, Caudwell P, Hellström PM, Näslund E,
King NA, et al. The adaptive metabolic response to exercise-
induced weight loss influences both energy expenditure and energy
intake. Eur J Clin Nutr. 2014;68:581–6. The authors show that
exercise-induced weight loss is resembles adaptive thermogene-
sis observed after diet-induced weight loss.
55. Bosy-Westphal A, Kossel E, Goele K, Later W, Hitze B, Settler U,
et al. Contribution of individual organ mass loss to weight loss-
associated decline in resting energy expenditure. Am J Clin Nutr.
2009;90:933–1001.
56. Pourhassan M, Glüer C-C, Pick P, Tigges W, Müller MJ. Effect of
different degrees of weight loss associated changes in detailed body
composition on insulin resistance. Eur J Clin Nutr. 2016, in press.
57. Lecoultre V, Ravussin E, Redman LM. The fall in leptin concentra-
tion is a major determinant of the metabolic adaptation induced by
caloric restriction independently of the changes in leptin circadian
rhythms. J Clin Endocrinol Metab. 2011;96:E1512–6.
58. Welle SL, Campbell RG. Decrease in resting metabolic rate during
rapid weight loss is reversed by low dose thyroid hormone treat-
ment. Metabolism. 1986;35:289–91.
59. Shetty PS, Jung RT, James WP. Effect of catecholamine replace-
ment with levodopa on the metabolic response to semistarvation.
Lancet. 1979;313(8107):77–79. Originally published as Volume
1, Issue 8107.
60. Acheson KJ, Burger AG. A study on the relationship between thermo-
genesis and thyroid hormones. J Clin Endocrin Metab. 1980;51:84–9.
61. DeFronzo RA. The effect of insulin on renal sodiummetabolism. A
review with clinical implications. Diabetologia. 1981;21:165–71.
62. Rothman DL, Magnusson I, Katz LD, Shulman RG, Shulman GI.
Quantitation of hepatic glycogenolysis and gluconeogenesis in
fasting humans with 13C NMR. Science. 1991;254:573–6.
63. Leibel R. Molecular physiology of weight regulation in mice and
humans. Int J Obes. 208; 32 (Suppl 7):S98-S108.
64. Rosenbaum M, Goldsmith R, Bloomfield D, Magnano A, Weimer
L, Heymsfield S, et al. Low-dose leptin reverses skeletal muscle,
autonomic, and neuroendocrine adaptations to maintenance of re-
duced weight. J Clin Invest. 2005;115:3579–86.
65.• Kissileff HR, Thornton JC, Torres MI, Pavlovich K, Mayer LS,
Kalari V, et al. Leptin reverses declines in satiation in weight-
reduced subjects. Am J Clin Nutr. 2012;95:309–17. Replacement
of leptin reversed 2/3 of the metabolic and neuroendocrine
adapatation to weight loss.
422 Curr Obes Rep (2016) 5:413–423
66. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH,
Prentice AM, et al. Effects of recombinant leptin therapy in a child
with congenital leptin deficiency. N Engl J Med. 1999;341:879–84.
67. Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R,
Hunt T, et al. Recombinant leptin for weight loss in obese and lean
adults: a randomized, controlled, dose-escalation trial. JAMA.
1999;282:1568–75.
68. Fogteloo AJ, Pijl H, Frölich M, McCamish M, Meinders AE.
Effects of recombinant human leptin treatment as an adjunct of
moderate energy restriction on body weight, resting energy expen-
diture and energy intake in obese humans. Diabetes Nutr Metab.
2003;16:109–14.
69. Korner J, Conroy R, Febres G,McMahon DJ, Conwell I, Karmally
W, et al. Randomized double-blind placebo-controlled study of lep-
tin administration after gastric bypass. Obesity. 2013;21:951–6.
70. Javor ED, Cochran EK, Musso C, Young JR, DePaoli AM, Gorden
P. Long-term efficacy of leptin replacement in patients with gener-
alized lipodystrophy. Diabetes. 2005;54:1994–2002.
71. Haas VK, Gaskin KJ, Kohn MR, Clarke SD, Müller MJ. Different
thermic effects of leptin in adolescent females with varying body fat
content. Clin Nutr. 2010;29:639–45.
72. Johnstone AM,Murison SD, Duncan JS, Rance KA, Speakman JR.
Factors influencing variation in basal metabolic rate include fat-free
mass, fat mass, age, and circulating thyroxine but not sex, circulat-
ing leptin, or triiodothyronine. Am J Clin Nutr. 2005;82:941–8.
73. Speakman JR. If body fatness is under physiological regulation,
then how come we have an obesity epidemic? Physiology.
2014;29:88–98.
74. Ferrannini E, Rosenbaum M, Leibel RL. The threshold shift para-
digm of obesity: evidence from surgically induced weight losss.
Am J Clin Nutr. 2014;100:996–1002.
75.• Rosenbaum M, Leibel RL. 20 years of leptin. Role of leptin in
energy homeostasis in humans. J Endocrinol. 2014;223:T83–96.
Summarizes the present state of the art on the role of leptin in
the regulation of energy balance.
76. Müller MJ, Bosy-Westphal A, Heymsfield SB. Is there evidence for
a set point that regulates human body weight? F1000 Med Rep.
2010;2:59.
77. Speakman JR, Levitsky DA, Allison DB, Bray MS, de Castro JM,
Clegg DJ, et al. Set points, settling points and some alternative
models: theoretical options to understand how genes and environ-
ments combine to regulate body adiposity. Dis Model Mech.
2011;4:733–45.
78. Hall KD, Chen KD, Guo J, Lam YY, Leibel RL, Mayer LES, et al.
Energy expenditure and body composition changes after an isoca-
loric ketogenic diet in overweight and obese men. Am J Clin Nutr.
2016;104:324–33.
79. Schutz Y. Human overfeeding experiments: potentials and limita-
tions in obesity research. Br J Nutr. 2000;84:135–7.
Curr Obes Rep (2016) 5:413–423 423
